BTX BioTime Inc.

$2.64 -2.58%

375,246 Shares Traded
452,131 Average Volume (last 30 days)

as of March 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $554.12 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-15.28%
If Intiated One Month Ago, Shorts Have Realized a Return of:-2.72%
If Initiated Five Days ago, Shorts Have Realized a Return of:5.38%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 7.01%
Short Interest7.92 million
Float112.98 million
Short Ratio18.37
Market Cap$334.93 million
Market Maker ActivityDaily Short Volume


BioTime's (BTX) CEO Adi Mohantyon Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
BioTime EPS of -$0.58 (SeekingAlpha)
BioTime Reports Fourth Quarter and Fiscal 2017 Results (Business Wire)
BioTime submits CE mark application for European approval of Renevia (SeekingAlpha)
BioTime Submits CE Mark Application for European Approval of Renevia® (Business Wire)
3 Things In Biotech, March 9: Amgen Rises, BioTime Advances, Caladrius Updates (SeekingAlpha)
Key events next week - healthcare (continued #6) (SeekingAlpha)
Your Daily Pharma Scoop: Esperion's Positive Data, Adamis Results, Mesoblast Gets Funding (SeekingAlpha)
BioTime advances clinical trial of OpRegen in dry AMD; shares up 2% (SeekingAlpha)
BioTime Announces DSMB Approval to Proceed to Cohort 4 of the OpRegen® Clinical Trial (Business Wire)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 18.9%

Earnings Stats

PE Ratio -10.15
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $2.72
50 Day Moving Average $2.72
52 Week High $3.59
52 Week Low $2.1

Data provided for free by IEX. Questions? Read the FAQ